{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:52:37Z","timestamp":1793505157524,"version":"4.5.0"},"reference-count":84,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1167\/iovs.62.3.2","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T11:31:26Z","timestamp":1614598286000},"page":"2","source":"Crossref","is-referenced-by-count":31,"title":["Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants"],"prefix":"10.1167","volume":"62","author":[{"given":"Anand","family":"Vinekar","sequence":"first","affiliation":[{"name":"Department of Pediatric Retina, Narayana Nethralaya, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana Padmanabhan","family":"Nair","sequence":"additional","affiliation":[{"name":"GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India"},{"name":"Manipal Academy of Higher Education, Manipal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Pediatric Retina, Narayana Nethralaya, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Vaidya","sequence":"additional","affiliation":[{"name":"GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India"},{"name":"Manipal Academy of Higher Education, Manipal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Chakrabarty","sequence":"additional","affiliation":[{"name":"GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkasubhra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India"},{"name":"Singapore Eye Research Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Sethu","sequence":"additional","affiliation":[{"name":"GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstrom","year":"2013","journal-title":"Lancet"},{"issue":"suppl 1","key":"bib2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of prematurity treatment: Asian perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)"},{"issue":"suppl 2","key":"bib4","first-page":"S80","article-title":"Can we stop the current epidemic of blindness from retinopathy of prematurity?","volume":"53","author":"Dutta","year":"2016","journal-title":"Indian Pediatr"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.siny.2015.05.002","article-title":"Role of tele-medicine in retinopathy of prematurity screening in rural outreach centers in India - a report of 20,214 imaging sessions in the KIDROP program","volume":"20","author":"Vinekar","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17469899.2019.1596026","article-title":"A review of treatment for retinopathy of prematurity","volume":"14","author":"Hansen","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1091-8531(97)90008-2","article-title":"Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity","volume":"1","author":"Young","year":"1997","journal-title":"J AAPOS"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fimmu.2017.01868","article-title":"Abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity","volume":"8","author":"Rathi","year":"2017","journal-title":"Front Immunol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"e0168809","DOI":"10.1371\/journal.pone.0168809","article-title":"Involvement of renin-angiotensin system in retinopathy of prematurity - a possible target for therapeutic intervention","volume":"11","author":"Nath","year":"2016","journal-title":"PLoS One"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4103\/0366-6999.164937","article-title":"Expression of total vascular endothelial growth factor and the anti-angiogenic VEGF 165 b isoform in the vitreous of patients with retinopathy of prematurity","volume":"128","author":"Zhao","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2147\/OPTH","article-title":"Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity","volume":"4","author":"Velez-Montoya","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","article-title":"Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ajo.2010.08.037","article-title":"Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity","volume":"151","author":"Sato","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbrc.2017.05.067","article-title":"Identification of vitreous proteins in retinopathy of prematurity","volume":"488","author":"Sugioka","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"bib22","article-title":"Intravitreal anti-vascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: a meta-analysis of 3701 eyes [published online ahead of print December 16, 2020]","author":"Popovic","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"bib23","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"2","author":"Sankar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bjophthalmol-2016-308828","article-title":"The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review","volume":"101","author":"Kandasamy","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1080\/14767058.2017.1338261","article-title":"The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study","volume":"31","author":"Kandasamy","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00417-020-04605-y","article-title":"A proposal of an algorithm for the diagnosis and treatment of recurrence or treatment failure of retinopathy of prematurity after anti-VEGF therapy based on a large case series","volume":"258","author":"Martinez-Castellanos","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib27","first-page":"576","article-title":"Angiogenin in age-related macular degeneration","volume":"17","author":"Skeie","year":"2011","journal-title":"Mol Vis"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/IAE.0000000000000157","article-title":"Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection","volume":"34","author":"Agawa","year":"2014","journal-title":"Retina"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/aos.2019.97.issue-3","article-title":"Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats' disease","volume":"97","author":"Zhang","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000267929","article-title":"Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy","volume":"28","author":"Ozaki","year":"1996","journal-title":"Ophthalmic Res"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/aos.12770","article-title":"Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration","volume":"93","author":"Fauser","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1006160209657","article-title":"Cell adhesion molecules in subretinal fluid: soluble forms of VCAM-1 (vascular cell adhesion molecule-1) and L-selectin","volume":"22","author":"Toker","year":"1998","journal-title":"Int Ophthalmol"},{"key":"bib33","first-page":"2453","article-title":"Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy","volume":"40","author":"Limb","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1076\/ceyr.19.3.219.5314","article-title":"Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy","volume":"19","author":"Barile","year":"1999","journal-title":"Curr Eye Res"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2337\/diacare.24.3.516","article-title":"Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study","volume":"24","author":"Hernandez","year":"2001","journal-title":"Diabetes Care"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1167\/iovs.07-0187","article-title":"Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis","volume":"48","author":"You","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib37","first-page":"756","article-title":"Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion","volume":"25","author":"Zeng","year":"2019","journal-title":"Mol Vis"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00417-018-4034-5","article-title":"Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab","volume":"256","author":"Lyu","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","article-title":"Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine","volume":"7","author":"Hagan","year":"2016","journal-title":"EPMA J"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative G","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1167\/iovs.19-26914","article-title":"Dysregulated tear fluid nociception-associated factors, corneal dendritic cell density, and vitamin D levels in evaporative dry eye","volume":"60","author":"Khamar","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.exer.2011.10.013","article-title":"Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy","volume":"93","author":"Zhao","year":"2011","journal-title":"Exp Eye Res"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00417-008-0865-9","article-title":"The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity","volume":"246","author":"Kwinta","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3928\/23258160-20131105-05","article-title":"Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity","volume":"44","author":"Yenice","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000351040","article-title":"Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity","volume":"104","author":"Levesque","year":"2013","journal-title":"Neonatology"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000317779","article-title":"Proliferative retinopathy is associated with impaired increase in BDNF and RANTES expression levels after preterm birth","volume":"98","author":"Hellgren","year":"2010","journal-title":"Neonatology"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1021\/bi00341a030","article-title":"Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells","volume":"24","author":"Fett","year":"1985","journal-title":"Biochemistry"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.onc.1208223","article-title":"Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis","volume":"24","author":"Kishimoto","year":"2005","journal-title":"Oncogene"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-04-2058","article-title":"Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation","volume":"65","author":"Tsuji","year":"2005","journal-title":"Cancer Res"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2106\/00004623-199173040-00016","article-title":"Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits","volume":"73","author":"King","year":"1991","journal-title":"Bone Joint J"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/abbs.2008.40.issue-7","article-title":"Mechanisms of action of angiogenin","volume":"40","author":"Gao","year":"2008","journal-title":"Acta Biochim Biophys Sin"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/abbs\/gmv131","article-title":"Three decades of research on angiogenin: a review and perspective","volume":"48","author":"Sheng","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2017.10.005","article-title":"Plexin-B2 mediates physiologic and pathologic functions of angiogenin","volume":"171","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ccell.2018.02.012","article-title":"Angiogenin\/ribonuclease 5 is an EGFR ligand and a serum biomarker for erlotinib sensitivity in pancreatic cancer","volume":"33","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1158\/0008-5472.CAN-05-3387","article-title":"Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors","volume":"66","author":"Amin","year":"2006","journal-title":"Cancer Res"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddm290","article-title":"Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension\/pathfinding and survival of motor neurons","volume":"17","author":"Subramanian","year":"2008","journal-title":"Human Mol Genet"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/cdd.2009.52","article-title":"Angiogenin protects motoneurons against hypoxic injury","volume":"16","author":"Sebastia","year":"2009","journal-title":"Cell Death Differ"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"e28797","DOI":"10.1371\/journal.pone.0028797","article-title":"Angiogenin enhances cell migration by regulating stress fiber assembly and focal adhesion dynamics","volume":"6","author":"Wei","year":"2011","journal-title":"PLoS One"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-010-0410-0","article-title":"Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells","volume":"340","author":"Cho","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jcmm.2012.16.issue-1","article-title":"Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts","volume":"16","author":"Jones","year":"2012","journal-title":"J Cell Mol Med"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"1984718","DOI":"10.1155\/2018\/1984718","article-title":"The potential of angiogenin as a serum biomarker for diseases: systematic review and meta-analysis","volume":"2018","author":"Yu","year":"2018","journal-title":"Dis Markers"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12906-016-1216-8","article-title":"Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivo","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.ajo.2007.07.022","article-title":"Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha","volume":"144","author":"Forooghian","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1378\/chest.129.2.266","article-title":"A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack","volume":"129","author":"Abdel-Rahman","year":"2006","journal-title":"Chest"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.oraloncology.2012.05.009","article-title":"Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer","volume":"48","author":"Kishimoto","year":"2012","journal-title":"Oral Oncol"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00894-017-3442-5","article-title":"The profile of angiogenic factors in vitreous humor of the patients with proliferative diabetic retinopathy","volume":"17","author":"Yu","year":"2017","journal-title":"Curr Mol Med"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2011.04.006","article-title":"Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy","volume":"82","author":"Marek","year":"2011","journal-title":"Microvasc Res"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/jnci\/92.16.1329","article-title":"Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis","volume":"92","author":"Byrne","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00408-005-2548-1","article-title":"Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia","volume":"183","author":"Parra","year":"2005","journal-title":"Lung"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.4049\/jimmunol.165.5.2818","article-title":"The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13","volume":"165","author":"Fukushi","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"bib77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/cancers11030321","article-title":"Bone marrow CX3CL1\/fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients","volume":"11","author":"Marchica","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cytogfr.2017.12.001","article-title":"Fractalkine and placental growth factor: a duet of inflammation and angiogenesis in cardiovascular disorders","volume":"39","author":"Skoda","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/cvr\/cvm067","article-title":"Activation of fractalkine\/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A\/KDR and reverses hindlimb ischaemia","volume":"78","author":"Ryu","year":"2008","journal-title":"Cardiovasc Res"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000316134","article-title":"Redundant mechanisms for vascular growth factors in retinopathy of prematurity in vitro","volume":"45","author":"Xiang","year":"2011","journal-title":"Ophthalmic Res"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/01.iae.0000244292.86627.1e","article-title":"Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP","volume":"26","author":"Gaynon","year":"2006","journal-title":"Retina"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40942-019-0203-x","article-title":"Retinopathy of prematurity: incidence report of outliers based on international screening guidelines","volume":"5","author":"Romo-Aguas","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"bib41","article-title":"Prevention of blindness from retinopathy of prematurity in neonatal care units","author":"Project operational guidelines"},{"key":"bib53","article-title":"Angiogenin","volume-title":"Encyclopedia of Molecular Biology","author":"Riordan","year":"2001"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:25Z","timestamp":1791927085000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.3.2","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}